Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 27. Februar 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7877  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 157533  
   
Preservation of cell-free RNA in percutaneous core-needle biopsy specimens' supernatants from non-small cell lung cancer improves genomic testing performance.
J Pathol Clin Res
Xu S, Ma YD, Bie ZX, Huang JY, Li YM, Wang Z, Li XG.
PMID: 41748474 [PubMed - in process]


Effect of Smoking Cessation Duration on Lung Cancer Incidence: A Nationwide Retrospective Cohort Study in Korea.
Cancer Res Treat
Choi MG, Kim MH, Kim HJ, Chun EM.
PMID: 41748108 [PubMed - as supplied by publisher]


PROSPECT-LUNG: A National Clinical Trials Network Trial Advancing Pragmatic Innovation in Cancer Clinical Trials.
J Thorac Oncol
Booth A, Hillman S, Laumann K, Zhao YQ, LeBlanc M, Chansky K, Giri S, Dill J, Johnson J, Kelley K, Martin L, Osarogiagbon RU, Morris MJ, Chiang AC, Kozono DE, Blanke CD, Galanis E, Gray JE, Stinchcombe TE, Aljumaily R, Morgensztern D, Mandrekar SJ.
PMID: 41747891 [PubMed - as supplied by publisher]


Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Cancer Treat Res Commun
Bironzo P, Morabito A, Silipigni S, Adamo V, Capelletto E, Rossi S, Tiseo M, Montrone M, Facilissimo I, Romano G, Masini LC, Ceresoli GL, Gridelli C, Lugini A, Pilotto S, Tagliaferri P, Bria E, Cortinovis D, Rijavec E, Borghetti P, Brighenti M, Carta AM, Ciuffreda L, Giusti R, Macerelli M, Verderame F, Zanelli F, Berardi R, Gregorc V, Sergi C, Vattemi E, Ferrara R, Piovano PL, Livi L, Borra G, Gori S, Aieta M, Bertolini A, Cecere FL, Pasello G, Rocco D, Certo GL, Marrone L, Simoni L, Roncari B, Novello S, Ramella S, BE-PACIFIC Study Group.
PMID: 41747469 [PubMed - as supplied by publisher]


Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study.
Ann Surg Oncol
Tane S, Nishikubo M, Manabe T, Watanabe T, Nomura K, Hamada A, Takamori S, Katsumata S, Shimizu N, Kojima H, Takamori S, Muto S, Abe M, Yoshikawa M, Suzuki J, Toda M, Okada S, Kano S, Ohde Y, Maniwa Y.
PMID: 41746575 [PubMed - as supplied by publisher]


Shared Plasma Fatty Acid Profiles in Four Cancer Types Enable Diagnosis and Discrimination of Gastrointestinal and Lung Cancers.
Metabolites
Hussain A, Shen K, Yan Y, Kang X, Xie L.
PMID: 41745608 [PubMed]


AACNN-ViT: Adaptive Attention-Augmented Convolutional and Vision Transformer Fusion for Lung Cancer Detection.
J Imaging
Rahman MI, Rahman A.
PMID: 41745427 [PubMed]


Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.
Curr Oncol
Cheema PK, Perdrizet KA, Sangha RS, Breadner D, Daaboul N, Farley S, Jao K, Liu G, Logan B, Melosky B, Reiman A, Snow S, Yadav S, Kassam S.
PMID: 41744848 [PubMed - in process]


Overcoming Immunotherapy Resistance in Small-Cell Lung Cancer.
Biology (Basel)
Canale M, Suzzi F, Verlicchi A, Citarella F, Delmonte A, Ulivi P.
PMID: 41744665 [PubMed]


Artificial Intelligence Approaches for Predictive Biomarker Discovery in Non-Small Cell Lung Cancer.
Technol Cancer Res Treat
Wang X, Liu N, Xu S, Xu T.
PMID: 41744418 [PubMed - in process]


A comprehensive review of clear cell stromal tumor of the lung: integrating clinicopathology and molecular pathogenesis.
Front Oncol
Luo L, Lv L, Zeng Y.
PMID: 41743955 [PubMed]


CT-based radiomics in predicting the efficacy of preoperative neoadjuvant chemoimmunotherapy for non-small cell lung cancer: a systematic review and meta-analysis.
Front Immunol
Chen H, Fan B, Yuan M, Wang D, Qiao C, Qiu N, Quan X, Hou W.
PMID: 41743740 [PubMed - in process]


PD-1/PD-L1 blockade in HIV-associated advanced lung cancer: from mechanisms to clinical practice.
Front Immunol
Chen R, Ren S, Tang H, Wu Q.
PMID: 41743729 [PubMed - in process]


Effectiveness of Lung Cancer Screening by Sex and Tumor Histology: Extended, Pooled Analysis of the ITALUNG and LUSI Trials, with Comparison to Findings in the NLST.
Cancer Commun (Lond)
Kaaks R, Cortés-Ibáñez FO, Delorme S, Motsch E, Katzke V, Heussel CP, Kauczor HU, Picozzi G, Gorini G, Carozzi FM, Carrozzi L, Paci E, Puliti D, Mascalchi M.
PMID: 41743631 [PubMed - in process]


The relationship between genetic mutations and organ metastasis in non-small cell lung cancer.
Ther Adv Med Oncol
Xue H, Chen Y, Qi F, Chen K, Liu X, Zhang M, Gao Z, Cai S, Gao T, Zhang T.
PMID: 41743381 [PubMed]


Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST MRI) in Lung Cancer: A Narrative Review of Translational Challenges and Clinical Potential.
Cureus
Dubey S.
PMID: 41743005 [PubMed]


Use of cell-free DNA in early detection of lung cancer: a proof-of concept study.
BMC Cancer
White LL, Maiyani M, Quintana LM, Powers JD, Nichols LE, Dollar B, Bedoy R, Martinez AE, Feigelson HS.
PMID: 41742078 [PubMed - as supplied by publisher]


Predictive role of vulnerable elderly study-13 screening tools in chemotherapy-related toxicity in elderly patients with lung cancer.
Sci Rep
Kara K, Cavdar E.
PMID: 41741613 [PubMed - as supplied by publisher]


Integration of Immune Checkpoint Blockade With Radiation in Lung Cancer: Lessons From Recent Trials.
Int J Radiat Oncol Biol Phys
Adib E, Willers H, Samson PP, Robinson CG, Keane FK.
PMID: 41741086 [PubMed - in process]


Lung and Bronchus Cancer - 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-Period: A Systematic Review of 588,785 Cases for Diagnosis Years 1975-2022.
J Insur Med
Milano AF.
PMID: 41740975 [PubMed - in process]


   
   Artikel 1 - 20 / 157533    Seite 1 von 7877  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1